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Outcome of Symptomatic Leg Ischaemia: Four Year Morbidity and 
Mortality in Vadstena, Sweden 
Bj6rn J6nsson* and Tommy Skau 
Department of Vascular Surgery, University Hospital, LinkOping, Sweden 
Objective: To quantify cardiovascular morbidity and mortality including the incidence of vascular surgery and 
amputations, among individuals with symptomatic leg ischaemia. 
Design: Prospective cohort study. 
Material: Inhabitants 50-89 years of age (n = 2 784) of Vadstena community, OstergOtland, Sweden, with 4 years of 
follow-up. 107 subjects with symptomatic leg ischaemia (SLI), selected by a postal questionnaire and ankle pressure 
measurements, and an age and sex matched control group of 214 individuals. 
Chief outcome measures: Cardiovascular morbidity and mortality, all cause mortality, surgical procedures for leg 
ischaemia, major amputations, ankle brachial pressure index. 
Main results: Age and sex adjusted all-cause mortality risk in the SLI-group was increased by 1.9. This was most 
prominent among men in their sixties and women in their seventies. Cardiovascular mortality was increased by 1.9 (95% 
confidence interval 1.1-3.3). Relative risks for acute myocardial infarction and cerebrovascular events were 2.4 (1.1-5.1) 
and 1.7 (0.9-3.2), respectively. The increase in age and sex adjusted incidence of primary reconstructive surgery during 
the first year after initial examination was 67-fold compared tothe total population of Vadstena 50-89 years old, and 18-fold 
for the whole observation period, while the increase in risk for major amputation during the observation period was 12-fold. 
Median ankle brachial index improved significantly during follow-up among the individuals alive and not subjected to
vascular surgery. 
Conclusions: Among the SLI-subjects identified ina general population, the overall risk for cardiovascular morbidity and 
mortality over 4 years was significantly increased compared to normals. 
Key Words: Epidemiology; Arterial occlusive disease; Mortality; Vascular surgery; Amputation; Ankle brachial pressure 
index; Prognosis. 
Introduction 
Epidemiological studies on atherosclerotic disease in 
the lower extremity are important to detect risk factors 
that could be influenced by prophylactic measures. 
Further, surgical and endovascular treatment possibil- 
ities for incapacitating or limb-threatening ischaemia 
have been developed uring the last decades. This 
enhances the need for studies on the magnitude of the 
problem and the natural course of the disease. Several 
studies on chronic leg ischaemia have shown 
increased mortality and morbidity from other athero- 
sclerotic manifestations such as myocardial infarction 
and stroke. 1-9 However, many follow-up studies 
performed to elucidate these questions have been 
hospital series 2"4 or were selected by gender and/or 
*Please address all correspondence to: Bj6rn J6nsson, Department of 
Vascular Surgery, University Hospital, S 581 85 Link6ping, 
Sweden. 
occupation 5'6'8"9 and often focused on claudication as a 
marker for generalised atherosclerotic disease. In a 
previous report, 1° the prevalence of all stages of 
symptomatic leg ischaemia (SLI) was estimated 
among all individuals of both sexes in a Swedish 
communit)9 50-89 years of age, using a postal ques- 
tionnaire and non-invasive t sting. The present study 
is a follow-up study of that cohort and aims at 
quantifying mortality and morbidity in the SLI-group 
in comparison with the general population. We there- 
fore focus on the outcome regarding both the local 
disease and other atherosclerotic manifestations. 
Material and Methods 
Setting for the study 
In 1989, Vadstena community was representative of 
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Table 1. Distribution of identified SLI-cases by age and sex in relation to total population in Vadstena 50-89 years of age. Prevalence in Y, 
with confidence intervals 
Both sexes SLI cases both sexes Men SLI cases men Women SLI cases women 
Age n n (%; 95% CI) n n (%; 95% CI) n n (%; 95% CI) 
50-59 820 12 (1.5; 0.7-2.3) 392 7 (1.8; 0.5-3.1) 427 5 (1.2; 0.2-2.2) 
60-69 882 32 (3.6; 2.4-4.8) 444 22 (5.0; 3.0-7.0) 437 10 (2.3; 0.9-3.7) 
70-79 717 45 (6.3; 4.5-8.1) 333 20 (6.0; 3.4-8.6) 388 25 (6.4; 4.0-8.8) 
8049 365 18 (4.9; 3.7-7.1) 131 8 (6.1; 2.0-10.2) 232 10 (4.3; 1.7-6.9) 
All ages 2,784 107 (3.8; 3.1-4.5) 1,300 57 (4.4; 3.3-5.5) 1,484 50 (3.4; 2.5-4.3) 
SLI=Symptomatic legischaemia. 
Sweden regarding age and sex distributions (Statis- 
tical Yearbook of Sweden 1990). The population is 
served by a district hospital  and a referral university 
hospital within the county. In July 1989, Vadstena 
community had a population of 7524 inhabitants, of 
whom 37% were 50-89 years of age. The population 
was stable during the follow-up period, as only 1.2% 
of the inhabitants aged 50-89 years moved out from 
the community during the 4 years of follow-up. These 
individuals were neglected in the analysis. 
Table 2. Frequencies of associated iseases and smoking among 
cases and controls, as reported in the questionnaire at the start of 
the study 
Cases Controls 
(n=107) % (n=214) % 
Diabetics, all 30 15 
Diabetics, insulin treated 20 5 
Previous myocardial infarction 25 7 
Angina pectoris 44 18 
Hypertension 51 30 
Cerebrovascular disease 10 2 
Smokers, active or previous 55 36 
Active smokers 28 14 
Study groups 
In 1989, individuals with symptomatic leg ischaemia 
were identified in two steps. At first, selection by a 
modified version of the WHO postal questionnaire 9 
was performed. The response rate was 92%. Those 
who reported leg pain on walking, regardless of 
answers to other questions in the questionnaire, were 
then selected for non-invasive testing. An ankle 
brachial pressure index (ABPI) of _< 0.8 was con- 
sidered to confirm the diagnosis. By this two-step 
method, 107 subjects were identified from the total 
population of 2784 individuals of both sexes, 50-89 
years old. The distribution of these cases with respect 
to age and gender is presented in Table 1. No study 
interventions were made, except for the distribution of 
written information about leg ischaemia including 
recommendations concerning tobacco smoking and 
physical activity at the time for the first examination. 
The distribution of risk factors as reported in the 
questionnaire are presented in Table 2. 
Among those who responded the questionnaire, an 
age and sex matched control group of 214 subjects was 
created. This was performed by choosing the two 
individuals that were positioned before and after each 
case, respectively, in the national registry. Cardiovas- 
cular morbidity and causes of death were compared 
between the SLI-group and these controls, while over- 
all mortality and utilisation of vascular surgery and 
amputations were compared to the total population of 
Vadstena. 
Follow-up 
The cohorts were followed prospectively for 4 years. 
Data on cardiovascular, cerebrovascular nd periph- 
eral vascular manifestations requiring in-hospital care, 
and data on open or endovascular surgical procedures 
and amputations were collected from the Patient 
Administrative System registry (PAS) of the county of 
Osterg6tland, thereby gathering information from in- 
hospital health care both from the local hospital and 
from the referral university hospital. Information of 
death causes was achieved from PAS and the Death 
Cause Registry, National Central Bureau of Statistics, 
Sweden. Local registers for vascular procedures at the 
two hospitals were reviewed, as were all records on 
patients ubjected to vascular surgery or amputation. 
No vascular econstructive procedures or amputations 
due to leg ischaemia on inhabitants of Vadstena 
younger than 50 years could be recorded uring the 
study period. 
After a mean observation time of 40 + 2 months, 
individuals in the SLI-group still alive were invited to 
another examination including an interview and arm 
and ankle blood pressure measurements, performed 
by a specially trained nurse. 
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ABPI measurements 
Measurements at the ankle were identically per- 
formed with an 8 MHz Doppler probe and a 12 cm 
blood pressure cuff. The highest of the recorded 
pressures in the posterior tibial and the dorsalis pedis 
arteries in the worst leg and the systolic arm pressure 
were included in the ABPI-calculation. At follow-up 
examination, pressures in the same leg were 
recorded. 
Definitions 
Cardiac event. In-hospital diagnosis of acute myocar- 
dial infarction, code 410, according to the WHO- 
classification (ICD-9), or death from acute myocardial 
infarction according to the death certificate. When an 
individual experienced more than one event, only the 
first was recorded. 
Cardiac death. In-hospital recording of fatal cardiac 
disease, ICD-codes 410-429, or death due to acute or 
chronic cardiac disease according to the death 
certificate. 
Cerebrovascular event. In-hospital diagnosis of acute 
cerebrovascular incident, codes 430-438, or death due 
to cerebrovascular disease according to the death 
certificate. When an individual experienced more than 
one event, only the first was recorded. 
Cerebrovascular death. In-hospital death due to any of 
codes 430-438, or death due to cerebrovascular disease 
according to the death certificate. 
Surgical procedure for leg ischaemia. Hospital record 
documentation of any reconstructive procedure (open 
or endovascular) indicated by symptoms of leg 
ischaemia. 
Primary procedure for chronic leg ischaemia. History of at 
least two weeks of symptoms of leg ischaemia before 
surger)~ as documented in the hospital record. Reo- 
perations after previous procedures for leg ischaemia 
were excluded. 
Overall cardiovascular morbidity, was defined as any of 
the following events: acute myocardial infarction, 
cerebrovascular event, surgical procedure for leg 
ischaemia or major amputation, surgical treatment for 
any other atherosclerotic manifestation (endovascular 
procedure for renal artery stenosis, coronary bypass 
surger)~ aortic aneurysm repair) or death due to 
atherosclerotic disease as recorded in the death 
certificate. 
Statistics 
Categorical variables were analysed by X 2 analysis 
with Yates' correction for continuity, or by Fisher's 
exact test when appropriate. The Mantel-Haenszel ~2 
test was used for comparison of age and sex adjusted 
mortality ratios. Standardisation was performed with 
the indirect method. Paired observations were ana- 
lysed by Wilcoxon signed rank test. Two-sided tests 
were always performed, and a p-value of less than 0.05 
was considered statistically significant. 95% con- 
fidence intervals for relative risks were calculated by 
the method of Katz et aI., ~1 unless otherwise stated. 
The cumulative survival without any event due to 
atherosclerotic disease was calculated for the SLI- 
group and the control group, respectivel~ using the 
life-table method. Deaths from other causes were not 
treated as events in this calculation. Survival analysis 
was performed on SPSS ® with the Lee-Desu statistic 
for overall comparisons. 
Results 
The control group was representative for those who 
responded to the questionnaire with respect to history 
of hypertension, ischaemic heart disease, cerebrovas- 
cular disease, diabetes and smoking habits when 
adjusted for age and gender. 
All-cause mortality 
Overall mortality during 4 years of follow-up was 
30/107 (28%) in the SLI-group and 293/2 677 (11%) 
among non-SLI subjects in the Vadstena population 
50-89 years of age (p < 0.0001). Age and sex adjusted 
mortality ratio for the SLI-group was 1.86 (Table 3). 
The statistically most prominent differences were 
noted for men in the seventh decade, and for women 
ten years older. For men over the age of 70, and for 
women over 80, no statistically significant differences 
could be seen compared to the rest of the population 
in corresponding age groups. 
Death certificates were available in 97% of deaths. 
Autopsy frequency was 13%. Seventy-five percent of 
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Table 3. Mortality in the SLI-group and in the rest of the Vadstena population aged 50-89 years by age and sex 
Vadstena population 
50-89 years of age (controls) SL~Group 
Deaths Deaths Age and sex adjusted 
n Deaths 1000/year n Deaths 1000/year mortality ratio p-value 
All men 1243 154 31 57 17 75 1.82 
Age: 
50-59 385 6 4 7 0 0 
60-69 422 25 15 22 5 57 3.8 (1.6-9.1)* 
70-79 313 61 49 20 6 75 1.5 (0.8-3.1) 
80-89 123 62 126 8 6 188 1.5 (0.96-2.3) 
All women 1434 139 24 50 13 65 1.93 
Age: 
50-59 422 3 2 5 0 0 
60-69 427 16 9 10 1 25 2.7 (0.4-18.2) 
70-79 363 40 28 25 9 90 3.3 (1.8-5.9) 
80-89 222 80 90 10 3 75 0.8 (0.3-2.2) 
0.0047 
0.0253 
AH 2677 293 27 107 30 70 1.86 0.0003 
* 95% confidence interval. 
Table 4. Frequencies of acute myocardial infarction, cerebrovascular events and death caused by vascular and non-vascular disease in th~ 
SLI-group and control group during four years of follow-up. For definitions, see Methods 
SLI-Group Controls 
Events Events Relative risk 95% CI 
Myocardial infarction; all 16/107 12/214 2.7 1.3-5.4 
Events (1000/year) 37.4 14.0 
No history of IHD 6/55 6/168 3.1 1.03-9.1 
Events (1000 / year) 27.3 8.9 
Cardiac deaths 13 / 107 13 / 107 2.0 0.964.2 
Events (1000/year) 30.4 15.2 
Cerebrovascular events 15/107 18/214 1.7 0.9-3.2 
Events (1000/year) 35.0 19.9 
No history of cerebrovasc 
disease 14/96 17/209 1.8 0.9-3.5 
Events (1000/year) 36.5 20.3 
Cerebrovascular deaths 6 / 107 8 / 214 1.5 0.5-4.2 
Events (1000/year) 14.0 9.3 
Cardiovascular deaths 22/107 23/214 1.9 1.1-3.3 
Events (1000/year) 51.4 26.9 
Other deathcauses 8/107 13/214 1.2 0.5-2.9 
Events (1000/year) 18.7 15.2 
IHD = ischaemic heart disease. 
the deaths  were  in -hosp i ta l .  Death  causes  among SLI- 
cases and  contro l  subjects ana lysed  by  d iagnos is -  
g roups  are presented  in Table 4. 
Cardiac morbidity and mortality 
Acute  myocard ia l  in farct ion  was  recorded  in  16 /107  of 
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Table 5. Frequencies and relative risks (with 95% confidence intervals) for myocardial infarction (MI events) and cerebrovascular events 
(CV events) in SLI-group (n=107) and age and sex matched control group (n=214), stratified by gender and age 
SLI-Group Controls Relative risk (95% CI) 
MI CV MI CV Myocardial Cerebrovascular 
events events n events events infarction event 
Men 
Age 
50-69 29 6 3 58 4 3 3.0 (0.9-9.8) 2.0 (0.4-9.3) 
70--89 28 5 5 56 6 5 1.7 (0.6-5.0) 2.0 (0.6-6.3) 
All men 57 11 8 114 10 8 2.2 (0.99-4.9) 2.0 (0.8-5.1) 
Women 
Age 
50~9 15 1 1 30 0 1 ~ 2.0 (0.1-29.8) 
7(~89 35 4 6 70 2 9 4.0 (0.8-20.8) 1.3 (0.5-3.4) 
All women 50 5 7 100 2 10 5.0 (1.01-24.9) 1.4 (0.6-3.5) 
the SLI-group (15%), and in 12/214 (6%) of the control 
group. The relative risk for acute myocardial infarc- 
tion in the SLI-group was therefore 2.7 (1.3-5.4) during 
the follow-up period (p = 0.0104) (Table 4). Individuals 
with history of ischaemic heart disease experienced a 
higher rate of myocardial infarction than those with- 
out in both SLI- and control groups (10/52 and 6/46 
vs. 6/55 and 6/168). The elevated risk in the SLI-group 
was, however, statistically significant only among 
those without history of ischaemic heart disease 
according to the questionnaire. The risk for cardiac 
death was doubled among SLI-subjects (Table 4). 
The risk for myocardial infarction was more pro- 
nounced for women than for men compared to the age 
and sex matched control group (Table 5). Younger men 
experienced a substantial risk increase for myocardial 
infarction compared to the controls, while the differ- 
ence among men 70 years or above was less emphas- 
ised. Among women, there was a tendency in the 
opposite direction with respect o age. 
Cerebrovascular morbidity and mortality 
Cerebrovascular events were recorded in 15/107 
(14%) of the SLI-group, and 18/214 (8%) in the control 
group, leading to a moderate but not statistically 
significant increase in the relative risk for SLI-subjects 
(Table 4). Most of the events occurred among individ- 
uals without previous insults. In both SLI- and control 
groups, the vast majority of events among women 
affected those above 70 years of age. For men, this 
difference was less pronounced (Table 5). 
Surgical procedures 
A total of 29 surgical procedures for leg ischaemia on 
Table 6. Incidence of vascular surgical procedures and major 
amputations in the Vadstena population 50-89 years of age during 
4 years of follow-up. Total incidence calculations are based on the 
whole population of Vadstena, while age and sex adjusted 
incidence ratios for SLI-cases are calculated to those 50-89 years 
(95% confidence interval by the method of Miettinen) 
Events Total Events Age and sex 
in total incidence within adjusted 
population (100,000/ SLI-group incidence 
(n=7524) year) (n=107) ratio 
Vascular surgery 
Procedures 
All 29 96 15 17.5 
Primary 18 60 10 20.5 
Patients 
All 22 73 11 16.6 
Primary 17 56 9 18.5 
Amputations 
Patients 12 40 5 11.6 
22 patients were recorded uring the follow-up period 
(Table 6). Some 11/2677 (0.4%) of the normal popula- 
tion 50-89 years of age, and 11/107 (10%) in the SLI- 
group were subjected to any vascular econstruction 
due to ischaemic disease. The indications for the 18 
primary procedures were rest pain, ischaemic ulcer or 
gangrene in eleven (61%), and incapacitating claudica- 
tion in seven cases. Four pr imary procedures (22%) 
were indicated by chronic critical ischaemia s defined 
by the European Consensus Document. 12 Ten of the 18 
primary procedures (56%) were performed on men. 
The SLI-group was accountable for 15 (52%) of all 
the procedures, and for 10 (56%) of the primary 
procedures. During the first year of follow-up 8/11 of 
the total number and 5/6 of the primary procedures 
were performed on SLI-subjects, giving an age and sex 
adjusted incidence ratio of 67.6 for pr imary recon- 
structive procedures. The proportion of SLI-subjects 
among the operated cases subsequently decreased 
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during the following years. The mean annual inci- 
dence figures for procedures indicated by leg ischae- 
mia are given in Table 6. 
Amputations 
The frequency of major amputations (above ankle) 
during 4 years of fol low-up was 7/2677 (0.3%) in non- 
SLI subjects 50-89 years of age and 5/107 (4.7%) 
among the SLI-cases. The annual amputat ion rate in 
the SLI-group was thereby 1.2%. The amputations 
were evenly distributed over the observation period. 
Among the 12 amputees, 11 were women and seven 
had been subjected to previous vascular surgery in the 
same leg. Five were diabetics. The overall incidence of 
major amputat ions in the Vadstena population was 
40/100 000/year (Table 6). 
Overall cardiovascular morbidity 
The cumulative survival free from any event due to 
cardiovascular disease was 57% in the SLI-group and 
80% in the control group during 4 years of fol low-up 
(p = 0.0001)(Fig. 1). 
Ankle pressure measurements 
The individuals with an ABPI between 0.8 and 1.0 at 
1 I
0.9 
0.8 - 
0.7 - 
0.6 - 
0.5 - 
0.4 - I I I I I I I I 
6 12 18 24 30 36 42 48 
Months 
Fig. 1. Cumulative all cardiovascular event-flee survival in SLI- (ll) 
and control ([2) groups during four years of follow-up. Cardiovas- 
cular events, fatal or non-fatal, any cardiovascular surgery indicated 
by atherosclerotic disease, and major amputation due to leg 
ischaemia re end-points. Death from other than cardiovascular 
cause was not regarded as an event in the calculation. Overall 
comparison: p = 0.0001. 
Table 7. Four year mortality rates in the study population with 
stratification by ankle brachial pressure indices. The reference 
group is composed by all inhabitants of Vadstena, 50-89 years of 
age, those with an ABPI ~ 1.0 at first examination excluded 
Age and sex 
Ankle brachial Deaths adjusted 
index (ABPI) n (%) mortality ratio p-value 
0.4 13 6 (46) 2.5 
0.6 48 14 (29) 1.8 
0.8 107 30 (28) 1.9 
_~ 0.9 163 36 (22) 1.6 
< 1.0 215 43 (20) 1.6 
0.8 < ABPI a 0.9 56 6 (11) 1.0 
0.9 < ABPI < 1.0 52 7 (13) 1.2 
Population 
50-89 years old; 
individuals with 2,569 280 (11) 1 
ABPI < 1.0 
exduded. 
0.0258 
0.0167 
0.0002 
0.0022 
0.0030 
0.8217 
0.6829 
first examination did not run an increased mortality 
risk, as the age and sex adjusted mortality ratio was 
similar among these and the normal populaation 
50-89 years of age, including those with leg symptoms 
but an ABPI of ~ 1.0 (Table 7). 
At the time for fol low-up examination, 25% of the 
SLI- subjects (27/107) were dead, and another eight 
(7%) had been subjected to vascular reconstructive 
surgery or amputation. Of the remaining 72 patients, 
61 (85%) accepted a second ABPI-measurement. A 
significant increase in ABPI in the affected leg was 
observed (median ABPI 0.65 and 0.70, respectively, 
p < 0.0001). Correction for regression to the mean with 
Oldham's transformation 13 revealed a positive slope 
of the regression line significantly different from zero 
(p = 0.0001). Insulin-treated diabetics howed a similar 
improvement to those without diabetes (Fig. 2). Seven 
out of 32 (22%) with an improved index by 15% or 
more reported subjective improvement,  while 15 
(46%) reported unchanged symptoms at follow-up. 
Discuss ion  
Atherosclerotic disease in the lower extremity is 
symptomatic only in a portion of subjects with non- 
inasively or angiographically detectable significant 
14--16 vascular stenoses or occlusions. From a ther- 
apeutic point of view, knowledge about the sympto- 
matic portion is the most important. When screening 
for SLI, the commonly used WHO-questionnaire, 
either in its inteview or postal version, 9'17 lacks 
sensitivity compared to non-invasive reference 
tests 8'18'19 and to doctors' assessment of symp- 
toms, 18"2° and is therefore not reliable. A recently 
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presented modification by Leng and Fowkes 18 might 
improve the usefulness in field surveys. In the 
previously reported Vadstena stud~ 1° the validity of 
the chosen survey method could not be evaluated in 
advance. In this stud~ any questionnaire-reported leg 
pain on walking qualified for further investigation. 
This symptom has later on proved to possess a 99% 
sensitivity. 18Specificity is, however, obviously low. An 
ABPI at 0.8 or less was chosen as cut-off level, based 
on previous angiographic validation. 21This is proba- 
bly at the cost of some claudicants with only margin- 
ally lowered ABPIs, or with pressure fall only at 
exercise. The present study showed, that while indi- 
viduals with an ABPI of 0.8 or less ran an increased 
mortality risk during follow-up, this was not the case 
for individuals with an ABPI between 0.8 and 1.0. This 
indicates that the chosen cut-off level selected individ- 
uals with both substantial local disease and consider- 
able general atherosclerotic disease. 
The most pronounced excess mortality risk among 
men in their sixties and women in their seventies, 
agrees with the generally held view that women 
acquire symptoms of advanced atherosclerotic disease 
later in life than men. With advancing age, excess 
mortality declines compared to controls among both 
men and women. 1As the mean age in this study is 
1.4 
1.2 
1.0 
~ 0.8 
0.6 
0.4 
0.2 
[] 
[] • 
[] r 
[] 
B• 
(e 0.75;2.25) 
[] 
[] [] 
[] ,,~ili!! 
0 0.2 0.4 0.6 0.8 1.0 1.2 1.4 
ABPIfirst 
Fig. 2. Ankle brachial index at start of the study (ABPI~st) plotted 
against value at follow-up (ABPI ..... d) in individuals with sympto- 
matic leg ischaemia. Values for the worst leg at initial examination 
recorded, n = 61. Subjects undergoing reconstructive surgery during 
follow-up eriod excluded. (O) insulin-treated diabetics; ([3) non- 
diabetics and diabetics without insulin treatment. Shaded zone 
represents nochange from first examination + 15%. Co-ordinates 
for one outlier at top of figure. 
higher than in most other follow-up studies, this 
explains why the total mortality risk increase was less 
pronounced than in previously reported surveys, ;  
The low autopsy frequency during the study period, 
making figures on death causes less reliable, is 
counteracted by the fact that the majority of deaths 
were in-hospital. The difference in mortality between 
SLI-subjects and controls was closely related to fatal 
cardiac disease, while other death causes were equally 
distributed. This indicates that SLI is an important 
predictor for cardiac events. 
The redoubled incidence of myocardial infarction 
among the SLI-subjects compared to the controls is in 
concordance with other studies on claudication, s-8'22 
This difference was due mainly to the individuals 
without a previous history of ischaemic heart disease, 
while risks were similar in both groups among those 
with previous heart disease as reported in the ques- 
tionnaire. Thus, ischaemic leg disease is in itself 
associated with an increased risk for myocardial 
infarction. Though the diagnosis of pre-existing heart 
disease was based only on the questionnaire, this is in 
accordance with results reported in other studies 
where more sophisticated evaluation was utilised, s'2a 
The correlation of cerebrovascular events to SLI was 
less pronounced here than in other studies, '23 The 
cerebrovascular events were not as closely related to 
SLI as were cardiac events. When all cardiovascular 
events were pooled together, almost half of the SLI- 
subjects however experienced at least one of these 
during 4 years of follow-up, thus additionally indicat- 
ing the high morbidity and mortality in the SLI- 
group. 
The vast majority of the individuals undergoing 
primary surgery for leg ischaemia during the first year 
of follow-up were covered by this survey. In that 
respect, the two-step survey method used was valid 
for the calculation of therapeutic demands. As 
expected, the proportion of candidates for surgery 
from the "normal" population increased uring the 
following years, and the proportion of SLI-subjects 
declined. The annual incidence of surgical procedures 
in the studied community was high compared to a 
recent British study 24 but in level with a previous 
report from the U.S.A. 25 As 60% of the primary 
procedures were indicated by rest pain or tissue loss, 
this corresponds to an annual incidence of recon- 
structive procedures ofapproximately 40/100 00. The 
primary procedures on individuals fulfilling the crite- 
ria for chronic ritical eg ischaemia 12correspond to an 
annual rate of 13/100000. With the assumption that 
the annual incidence of chronic critical eg ischaemia 
as defined in the European Consensus Document is 
50-100/100000 and, based on the same document, 
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that one third of patients will require a reconstructive 
procedure, la this calculation suggests that vascular 
surgical activity may still be sub-optimal. 
The total amputation rate in the present study was 
high compared to other incidence studies, a6'a7 but 
showed little difference compared to a previous tudy 
on major amputations in the same county, a8 The 
incidence of amputations among non-diabetics was 
estimated to approximately 25/100000, which is in 
accordance with other reports, la'a6 The high share of 
women among the amputees could reflect the aged 
population under stud)~ as elderly women have a high 
prevalence of SLI, and their incidence rates for 
vascular surgery increases considerably with advanc- 
ing age. a9 As amputation rates are highly dependent 
on the age composition of the population and the 
prevalence of diabetes, direct comparisons with other 
surveys are difficult. It is still a question of debate to 
what extent vascular surgery can influence the ampu- 
tation rate. 
The recorded improvement of ankle-arm indices 
over time in a considerable part of the individuals 
with leg ischaemia is in accordance with other 
studies, a°'3° There are several possible xplanations to 
this finding. The population that had a second 
examination was highly selected, as individuals with 
progression of local disease requiring surgery were 
excluded. Stiffening of the leg arteries might produce 
falsely elevated ankle pressures, especially among 
diabetics. 3L32 There was, however, no difference in the 
development of the ABPI:s between diabetics and non 
diabetics in the study. The examination procedure in 
itself may also constitute a source of error especially as 
advice was given about smoking and exercise. A 
guarded conclusion is that the majority of the individ- 
uals with SLI show no signs of progression of local 
disease, regardless of other manifestations of athero- 
sclerotic disease. 
In summar)~ the combination of a simple postal 
questionnaire and non-invasive testing in selected 
cases is a valid method to detect individuals with 
symptomatic leg ischaemia. The results demonstrate a 
significantly increased morbidity and mortality due to 
generalised atherosclerotic disease among individuals 
with leg ischaemia. 
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